Display options
Cite
Guzzo C, Ichikawa D, Park C, et al. Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing. Sci Immunol. 2017;2(11)doi: 10.1126/sciimmunol.aam7341.
Guzzo, C., Ichikawa, D., Park, C., Phillips, D., Liu, Q., Zhang, P., Kwon, A., Miao, H., Lu, J., Rehm, C., Arthos, J., Cicala, C., Cohen, M. S., Fauci, A. S., Kehrl, J. H., & Lusso, P. (2017). Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing. Science immunology, 2(11), . https://doi.org/10.1126/sciimmunol.aam7341
Guzzo, Christina, et al. "Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing." Science immunology vol. 2,11 (2017). doi: https://doi.org/10.1126/sciimmunol.aam7341
Guzzo C, Ichikawa D, Park C, Phillips D, Liu Q, Zhang P, Kwon A, Miao H, Lu J, Rehm C, Arthos J, Cicala C, Cohen MS, Fauci AS, Kehrl JH, Lusso P. Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing. Sci Immunol. 2017 May 12;2(11). doi: 10.1126/sciimmunol.aam7341. PMID: 28763793; PMCID: PMC5653278.
Copy Download .nbib Format: NLM
Share it on

Sci Immunol. 2017 May 12;2(11). doi: 10.1126/sciimmunol.aam7341.

Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing.

Science immunology

Christina Guzzo, David Ichikawa, Chung Park, Damilola Phillips, Qingbo Liu, Peng Zhang, Alice Kwon, Huiyi Miao, Jacky Lu, Catherine Rehm, James Arthos, Claudia Cicala, Myron S Cohen, Anthony S Fauci, John H Kehrl, Paolo Lusso

Affiliations

  1. Viral Pathogenesis Section, Laboratory of Immunoregulation (LIR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  2. B-Cell Molecular Immunology Section, LIR, NIAID, NIH, Bethesda, MD 20892, USA.
  3. Clinical Research Section, LIR, NIAID, NIH, Bethesda, MD 20892, USA.
  4. Immunopathogenesis Section, LIR, NIAID, NIH, Bethesda, MD 20892, USA.
  5. Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  6. Viral Pathogenesis Section, Laboratory of Immunoregulation (LIR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA. [email protected].

PMID: 28763793 PMCID: PMC5653278 DOI: 10.1126/sciimmunol.aam7341

Abstract

The intestinal mucosa is a key anatomical site for HIV-1 replication and CD4

Copyright © 2017, American Association for the Advancement of Science.

References

  1. Science. 1992 Dec 18;258(5090):1935-8 - PubMed
  2. Mucosal Immunol. 2008 Jan;1(1):23-30 - PubMed
  3. Cell Adh Migr. 2012 Jan-Feb;6(1):20-9 - PubMed
  4. Clin Gastroenterol Hepatol. 2016 Nov;14 (11):1593-1601.e2 - PubMed
  5. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5067-72 - PubMed
  6. Nature. 2003 Mar 20;422(6929):307-12 - PubMed
  7. J Exp Med. 2004 Sep 20;200(6):749-59 - PubMed
  8. Curr Drug Targets. 2013 Nov;14(12):1433-43 - PubMed
  9. J Virol. 2002 Feb;76(3):1004-14 - PubMed
  10. EBioMedicine. 2016 Aug;10 :45-54 - PubMed
  11. J Transl Med. 2011 Jan 27;9 Suppl 1:S2 - PubMed
  12. J Virol. 2015 Jan;89(1):323-36 - PubMed
  13. Bioorg Med Chem Lett. 2013 Aug 1;23(15):4370-3 - PubMed
  14. Elife. 2015 Aug 10;4:null - PubMed
  15. J Virol. 2000 Apr;74(7):3264-72 - PubMed
  16. J Virol. 2003 Nov;77(22):12299-309 - PubMed
  17. J Immunol. 1984 Oct;133(4):1857-62 - PubMed
  18. Am J Pathol. 1997 Jul;151(1):97-110 - PubMed
  19. Infect Immun. 2000 Oct;68(10):5587-94 - PubMed
  20. Science. 2014 Mar 21;343(6177):1243727 - PubMed
  21. Science. 2015 Oct 30;350(6260):563-567 - PubMed
  22. Infect Immun. 1997 Dec;65(12):5198-208 - PubMed
  23. J Virol. 1997 May;71(5):3588-96 - PubMed
  24. Nat Immunol. 2008 Mar;9(3):301-9 - PubMed
  25. J Virol. 1997 Jun;71(6):4847-51 - PubMed
  26. Biochem J. 1996 Feb 1;313 ( Pt 3):899-908 - PubMed
  27. J Cell Sci. 2011 May 15;124(Pt 10):1672-80 - PubMed
  28. Nat Med. 2014 Dec;20(12):1397-400 - PubMed
  29. Mucosal Immunol. 2009 Nov;2(6):518-26 - PubMed
  30. Science. 2016 Oct 14;354(6309):197-202 - PubMed
  31. Nat Rev Immunol. 2005 Oct;5(10):783-92 - PubMed
  32. Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9569-74 - PubMed
  33. Clin Immunol. 2004 Jun;111(3):275-85 - PubMed
  34. PLoS Pathog. 2012;8(4):e1002636 - PubMed
  35. Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3152-7 - PubMed
  36. Science. 2016 Oct 14;354(6309):157-158 - PubMed
  37. J Immunol. 2015 Mar 1;194(5):2415-23 - PubMed
  38. Proc Natl Acad Sci U S A. 1985 May;82(10):3197-201 - PubMed
  39. J Pharmacol Exp Ther. 2000 Dec;295(3):979-85 - PubMed
  40. J Immunol. 1996 Apr 15;156(8):2851-7 - PubMed
  41. Clin Drug Investig. 2016 Nov;36(11):913-923 - PubMed
  42. J Immunol. 2011 Dec 1;187(11):6032-42 - PubMed
  43. Virology. 2005 May 10;335(2):286-90 - PubMed
  44. Immunity. 2004 Oct;21(4):527-38 - PubMed
  45. J Gen Virol. 1993 Jan;74 ( Pt 1):129-35 - PubMed
  46. Immunol Today. 1998 Aug;19(8):346-51 - PubMed
  47. Nature. 2005 Apr 28;434(7037):1148-52 - PubMed
  48. Nat Protoc. 2008;3(7):1240-8 - PubMed
  49. J Immunol. 2011 Jan 15;186(2):1044-59 - PubMed
  50. Dig Dis. 2016;34(1-2):153-9 - PubMed
  51. Virology. 2004 Jun 20;324(1):165-72 - PubMed
  52. J Virol. 2001 Jul;75(13):6173-82 - PubMed
  53. Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905 - PubMed

Publication Types

Grant support